Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.635 SEK | -2.01% | -17.96% | -16.94% |
06-20 | Transcript : Egetis Therapeutics AB - Special Call | |
06-19 | Egetis Therapeutics AB Announces Topline Results of the Phase 2 Triac Trial II with Emcitate for MCT8 Deficiency | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.94% | 130M | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- EGTX Stock
- News Egetis Therapeutics AB
- Transcript : PledPharma AB - Special Call